These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37788303)

  • 21. Longterm corticosteroid use after liver transplantation for autoimmune hepatitis is safe and associated with a lower incidence of recurrent disease.
    Krishnamoorthy TL; Miezynska-Kurtycz J; Hodson J; Gunson BK; Neuberger J; Milkiewicz P; Oo YH
    Liver Transpl; 2016 Jan; 22(1):34-41. PubMed ID: 26335026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rejection and steroid dependence: unique risk factors in the development of pediatric posttransplant de novo autoimmune hepatitis.
    Venick RS; McDiarmid SV; Farmer DG; Gornbein J; Martin MG; Vargas JH; Ament ME; Busuttil RW
    Am J Transplant; 2007 Apr; 7(4):955-63. PubMed ID: 17391135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term results of pediatric liver transplantation for autoimmune liver disease.
    Couchonnal E; Jacquemin E; Lachaux A; Ackermann O; Gonzales E; Lacaille F; Debray D; Boillot O; Guillaud O; Wildhaber BE; Chouik Y; McLin V; Dumortier J
    Clin Res Hepatol Gastroenterol; 2021 May; 45(3):101537. PubMed ID: 33077391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease.
    Ratziu V; Samuel D; Sebagh M; Farges O; Saliba F; Ichai P; Farahmand H; Gigou M; Féray C; Reynès M; Bismuth H
    J Hepatol; 1999 Jan; 30(1):131-41. PubMed ID: 9927160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence and risk factors associated with de novo autoimmune hepatitis after liver transplantation.
    Montano-Loza AJ; Vargas-Vorackova F; Ma M; Bain VG; Burak K; Kumar T; Mason AL
    Liver Int; 2012 Oct; 32(9):1426-33. PubMed ID: 22712495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased risk of portal vein thrombosis in patients with autoimmune hepatitis on the liver transplantation waiting list.
    Ruiz P; Sastre L; Crespo G; Blasi A; Colmenero J; García-Valdecasas JC; Navasa M
    Clin Transplant; 2017 Jul; 31(7):. PubMed ID: 28489255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Possible benefit of splenectomy in liver transplantation for autoimmune hepatitis.
    Xu YT; Liu DJ; Meng FY; Li GB; Liu J
    Hepatobiliary Pancreat Dis Int; 2014 Jun; 13(3):328-31. PubMed ID: 24919618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver transplantation for autoimmune hepatitis.
    Reich DJ; Fiel I; Guarrera JV; Emre S; Guy SR; Schwartz ME; Miller CM; Sheiner PA
    Hepatology; 2000 Oct; 32(4 Pt 1):693-700. PubMed ID: 11003612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative Analysis of the Clinical Outcomes of Liver Transplantation for Probable and Definite Auto-immune Hepatitis by International Diagnostic Scoring Criteria.
    Cho CW; Kwon CHD; Kim JM; Choi GS; Joh JW; Lee SK
    Transplant Proc; 2017 Jun; 49(5):1126-1128. PubMed ID: 28583541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver transplantation for autoimmune hepatitis in Peru: outcomes and recurrence.
    Padilla M; Mayorga R; Carrasco F; Bedregal T; Bobadilla F; Rondón C; Chaman J
    Ann Hepatol; 2012; 11(2):222-7. PubMed ID: 22345339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential benefit of mixed lymphocyte reaction assay-based immune monitoring after living donor liver transplantation for recipients with autoimmune hepatitis.
    Sakai H; Ishiyama K; Tanaka Y; Ide K; Ohira M; Tahara H; Abe T; Hirata F; Morimoto H; Hashimoto S; Tanimine N; Saeki Y; Shimizu S; Yano T; Kobayashi T; Tashiro H; Ohdan H
    Transplant Proc; 2014 Apr; 46(3):785-9. PubMed ID: 24767349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long Term Outcomes of Liver Transplantation For Patients With Autoimmune Hepatitis.
    Alswat K; Soliman E; Salih I; Bashmail A; Letierce A; Benmousa A; Alghamdi S; Bzeizi KI; Alqahtani SA; Shawkat M; Broering DC; Al-Hamoudi WK
    Transplant Proc; 2021 Sep; 53(7):2339-2345. PubMed ID: 34474912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver transplantation for autoimmune hepatitis and the success of aggressive corticosteroid withdrawal.
    Campsen J; Zimmerman MA; Trotter JF; Wachs M; Bak T; Steinberg T; Kaplan M; Wright F; Kam I
    Liver Transpl; 2008 Sep; 14(9):1281-6. PubMed ID: 18756454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term outcome of liver transplantation for autoimmune hepatitis.
    Vogel A; Heinrich E; Bahr MJ; Rifai K; Flemming P; Melter M; Klempnauer J; Nashan B; Manns MP; Strassburg CP
    Clin Transplant; 2004 Feb; 18(1):62-9. PubMed ID: 15108772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A 10 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence.
    Duclos-Vallée JC; Sebagh M; Rifai K; Johanet C; Ballot E; Guettier C; Karam V; Hurtova M; Feray C; Reynes M; Bismuth H; Samuel D
    Gut; 2003 Jun; 52(6):893-7. PubMed ID: 12740348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of infectious complications and timing for emergency liver transplantation in autoimmune acute liver failure.
    Fujiwara K; Yasui S; Yonemitsu Y; Arai M; Kanda T; Fukuda Y; Nakano M; Oda S; Yokosuka O
    J Hepatobiliary Pancreat Sci; 2016 Apr; 23(4):212-9. PubMed ID: 26808231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for recurrent autoimmune liver diseases after liver transplantation: A meta-analysis.
    Chen C; Ke R; Yang F; Cai Q; Liu J; Huang X; Chen J; Xu F; Jiang Y
    Medicine (Baltimore); 2020 May; 99(20):e20205. PubMed ID: 32443344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoimmune Hepatitis in the Liver Transplant Graft.
    Beal EW; Black SM; Michaels A
    Clin Liver Dis; 2017 May; 21(2):381-401. PubMed ID: 28364820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis.
    Colapietro F; Maisonneuve P; Lytvyak E; Beuers U; Verdonk RC; van der Meer AJ; van Hoek B; Kuiken SD; Brouwer JT; Muratori P; Aghemo A; Carella F; van den Berg AP; Zachou K; Dalekos GN; Di Zeo-Sánchez DE; Robles M; Andrade RJ; Montano-Loza AJ; van den Brand FF; Slooter CD; Macedo G; Liberal R; de Boer YS; Lleo A; ;
    J Hepatol; 2024 Jan; 80(1):53-61. PubMed ID: 37802188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammatory bowel disease after liver transplantation: risk factors for recurrence and de novo disease.
    Verdonk RC; Dijkstra G; Haagsma EB; Shostrom VK; Van den Berg AP; Kleibeuker JH; Langnas AN; Sudan DL
    Am J Transplant; 2006 Jun; 6(6):1422-9. PubMed ID: 16686766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.